# Novel Laboratories, Inc. d.b.a Lupin Somerset - Inspection Records

Source: https://www.keypedia.com/companies/novel-laboratories-inc-dba-lupin-somerset/53a42119-c077-49fb-b739-db29c2b99391

> Inspection records and compliance data for Novel Laboratories, Inc. d.b.a Lupin Somerset in Somerset, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Novel Laboratories, Inc. d.b.a Lupin Somerset
- FEI Number: 3006271438
- City: Somerset
- State: New Jersey
- Country Name: United States
- Address Line 1: 400 Campus Dr
- Zip Code: 08873
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2026-04-17](https://www.keypedia.com/records/483/novel-laboratories-inc-dba-lupin-somerset/ab639fd7-fe3c-40a5-aa57-08ed392c7c15) — source: FDA, date: April 17, 2026
- [FDA Inspection 1306616 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2026-04-17](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/3929d635-0f63-4a0a-b47f-d35102bc3d33) — source: FDA, date: April 17, 2026
- [483 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2025-10-10](https://www.keypedia.com/records/483/novel-laboratories-inc-dba-lupin-somerset/b504ca40-96c7-4e92-badd-0df5d3642eea) — source: FDA, date: October 10, 2025
- [FDA Inspection 1285934 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2025-10-10](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/68e0ace3-c682-4a1c-bb76-34bb3f2712bd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 10, 2025
- [FDA Inspection 1285934 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2025-10-10](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/dfddb031-7d66-4dc1-82ad-c66090b0c800) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 10, 2025
- [FDA Inspection 1259938 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2025-01-31](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/79f379b8-551a-4c4d-b825-72508514c6fd) — source: FDA, date: January 31, 2025
- [FDA Inspection 1235495 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2024-05-17](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/da7fdbc2-3b68-4bd4-bebb-447e90336803) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 17, 2024
- [FDA Inspection 1235495 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2024-05-17](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/47eb9329-2372-4457-9525-d2df8c6bc801) — classification: No Action Indicated (NAI), source: FDA, date: May 17, 2024
- [483 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2023-01-13](https://www.keypedia.com/records/483/novel-laboratories-inc-dba-lupin-somerset/2dd544ba-ef47-4a02-8afc-afbe901915b8) — source: FDA, date: January 13, 2023
- [FDA Inspection 1197049 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2023-01-13](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/c29bdd8e-f68a-4554-b27f-a094c6c578d0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 13, 2023
- [483 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2022-03-30](https://www.keypedia.com/records/483/novel-laboratories-inc-dba-lupin-somerset/d2442992-2045-48b7-a2c8-31301ba9b7c1) — source: FDA, date: March 30, 2022
- [FDA Inspection 1168160 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2022-03-30](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/5a65ed50-592e-4c81-9120-8d691193d983) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 30, 2022
- [483 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2020-11-05](https://www.keypedia.com/records/483/novel-laboratories-inc-dba-lupin-somerset/9907ffb3-8bee-4e52-898f-44353c6b0620) — source: FDA, date: November 5, 2020
- [483 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2020-11-05](https://www.keypedia.com/records/483/novel-laboratories-inc-dba-lupin-somerset/5b4aee89-c5fd-487d-89cc-dbac6cbe518e) — source: FDA, date: November 5, 2020
- [WARNING_LETTER - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2020-11-05](https://www.keypedia.com/records/warning_letter/novel-laboratories-inc-dba-lupin-somerset/8db1077e-e83a-4e3a-8141-a77b0e62df2c) — source: FDA, date: November 5, 2020
- [FDA Inspection 1133661 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2020-11-05](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/d1fc9285-045e-4581-8571-b1a5c6599dc3) — classification: Official Action Indicated (OAI), source: FDA, date: November 5, 2020
- [483 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2018-12-21](https://www.keypedia.com/records/483/novel-laboratories-inc-dba-lupin-somerset/340a2fdf-3c8d-4b48-b06d-a8bd3e42146e) — source: FDA, date: December 21, 2018
- [FDA Inspection 1071709 - Novel Laboratories, Inc. d.b.a Lupin Somerset - 2018-11-08](https://www.keypedia.com/records/fda_inspections/novel-laboratories-inc-dba-lupin-somerset/ced7bfaf-e380-44a1-a2f7-e88bb5dd55b7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 8, 2018

## Related Companies

- [Strides Pharma, Inc.](https://www.keypedia.com/companies/strides-pharma-inc/e9e4da51-c260-486c-8969-86d64b9b36af)
- [HP Halden Pharma AS](https://www.keypedia.com/companies/hp-halden-pharma-as/2c8c6d51-da3a-476a-9abd-da411b527728)
- [Bestco LLC](https://www.keypedia.com/companies/bestco-llc/27c6f984-ce98-4bb5-8be5-7124d6a4aade)
- [Cerovene Inc.](https://www.keypedia.com/companies/cerovene-inc/f23e944b-ef46-45b3-8177-af154b404c08)
- [USpharma Ltd](https://www.keypedia.com/companies/uspharma-ltd/964df153-5c44-460a-949f-69325271a2b1)
- [Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/otsuka-pharmaceutical-co-ltd/4106c23b-a243-4485-8ab6-a3dd8a7258ad)
- [Peptech Animal Health Pty Ltd.](https://www.keypedia.com/companies/peptech-animal-health-pty-ltd/2bcd385c-dd88-495b-8528-f459ac708de7)
- [Haupt Pharma Latina Srl](https://www.keypedia.com/companies/haupt-pharma-latina-srl/0976ff44-458f-4749-a2d5-3d2728a17a6d)
- [AXXELENT PHARMA SCIENCE PRIVATE LIMITED](https://www.keypedia.com/companies/axxelent-pharma-science-private-limited/0e17ded9-51c9-4db9-9ceb-e39cb2d439db)
- [Baxalta US Inc.](https://www.keypedia.com/companies/baxalta-us-inc/dbfac016-3c29-44aa-845b-d79000c4abd2)

## Related Officers

- [Lata C. Mathew](https://www.keypedia.com/people/lata-c-mathew/0610a0ef-dcc5-43e7-ab74-2ac54d758beb)
- [Jogy George](https://www.keypedia.com/people/jogy-george/00ef0915-66d2-4b34-9b74-d1e08caf2db3)
- [issuing_officer](https://www.keypedia.com/people/ko-min/767a6604-9a34-49c7-8462-c763c2689f61)
- [Investigator](https://www.keypedia.com/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)